drugset / Trial / NCT04401527
Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This multicenter, randomized, double-blind, placebo-controlled clinical trial will evaluate the efficacy and safety of intravenous Sodium Nitrite Injection for treatment of patients infected with COVID-19 who develop lung injury and require mechanical ventilation.
Timeline
- Start
- 2020-07-22
- Primary completion
- 2020-08-15
- Completion
- 2020-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sodium Nitrite | Small molecule | — | Intravenous |